Ansa Biotechnologies

Ansa Biotechnologies is a synthetic DNA manufacturer headquartered in Emeryville, California, founded in 2017 as a UC Berkeley spinout. Its enzymatic DNA synthesis platform is built on TdT-dNTP conjugates — enzymatic reagents that add single bases to a growing DNA molecule — and is sold as a made-to-order laboratory service producing sequence-verified double-stranded DNA fragments up to 600 bp, clonal DNA up to 7.5 kb, and ultra-long clonal constructs up to 50 kb. Quotes and orders are placed through a Salesforce Experience Cloud customer portal at portal.ansabio.com. Ansa is a wet-lab manufacturer rather than a software company: it publishes no public API, developer portal, SDK, or machine-readable specification.

Ansa Biotechnologies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Synthetic Biology, DNA Synthesis, and Gene Synthesis.

Ansa Biotechnologies’ developer surface includes engineering blog, support, and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.5/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologySynthetic BiologyDNA SynthesisGene SynthesisLife SciencesLaboratory Services

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 13.5/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 5.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 3.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ansa-biotechnologies: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 1

Portal, sign-up, and the first successful call

Login

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: ansa-biotechnologies
name: Ansa Biotechnologies
description: 'Ansa Biotechnologies is a synthetic DNA manufacturer headquartered in Emeryville, California, founded in 2017
  as a UC Berkeley spinout. Its enzymatic DNA synthesis platform is built on TdT-dNTP conjugates — enzymatic reagents that
  add single bases to a growing DNA molecule — and is sold as a made-to-order laboratory service producing sequence-verified
  double-stranded DNA fragments up to 600 bp, clonal DNA up to 7.5 kb, and ultra-long clonal constructs up to 50 kb. Quotes
  and orders are placed through a Salesforce Experience Cloud customer portal at portal.ansabio.com. Ansa is a wet-lab manufacturer
  rather than a software company: it publishes no public API, developer portal, SDK, or machine-readable specification.'
url: https://raw.githubusercontent.com/api-evangelist/ansa-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-source-url: https://forgeglobal.com/ansa-biotechnologies_stock/
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Synthetic Biology
- DNA Synthesis
- Gene Synthesis
- Life Sciences
- Laboratory Services
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ansa-biotechnologies-domain-security.yml
- type: Website
  url: https://ansabio.com/
- type: Blog
  url: https://ansabio.com/topic/blog/
- type: Support
  url: https://ansabio.com/customer-support/
- type: Login
  url: https://portal.ansabio.com/
- type: TermsOfService
  url: https://ansabio.com/terms-and-conditions/
- type: PrivacyPolicy
  url: https://ansabio.com/privacy-policy/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Ansa sells wet-lab DNA synthesis, not software — ordering runs through a Salesforce Experience Cloud customer portal
    (portal.ansabio.com) whose every path, real or not, returns the same login HTML, and the corporate site answers every
    probe including /robots.txt with a SiteGround sgcaptcha challenge; no API, spec, SDK, package or GitHub org exists on
    any host or registry.
  evidence:
  - url: https://ansabio.my.site.com/openapi.json
    status: 404
  - url: https://ansabio.my.site.com/.well-known/agent-card.json
    status: 404
  - url: https://portal.ansabio.com/openapi.json
    status: 200
  - url: https://ansabio.com/llms.txt
    status: 202
  - url: https://api.github.com/orgs/ansabio
    status: 404
  checked: '2026-08-06'